Michael Messinger, CPA
Chief Financial Officer
Mr. Messinger has served as our Chief Financial Officer since November 2018. Prior to that, he had served as Vice President of Finance since November 2012. Mr. Messinger has more than 20 years of experience in finance and accounting for research and clinical development organizations. He served as Controller of Coelacanth Corporation, enabling the successful completion of its acquisition. Mr. Messinger continued in the role of Director of Finance for Lexicon Pharmaceuticals, Inc. In this capacity, he was responsible for the financial management of Lexicon's partnership with Symphony Capital, LLC, in addition to coordinating budgeting, forecasting and program management for Lexicon's portfolio of clinical development programs.
Mr. Messinger received his B.B.A degree, with distinction, in accounting from the University of Michigan, where he was elected Beta Alpha Psi and Order of Omega. He started his career as an auditor at Ernst & Young, LLP.